10
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

      1 , 2 , 3 , 4 , 5 , 6 , 6 , 6 , 2 , 7 , 8 , 7 , 9 , 7 , 10 , 7 , 11 , 12 , 13 , 13 , 7 , 14
      The Journal of allergy and clinical immunology
      BM, Bone marrow, CLMast, Hymenoptera, ISM, ISMs(+), ISMs(−), Indolent systemic mastocytosis, Indolent systemic mastocytosis with skin lesions, Indolent systemic mastocytosis without skin lesions, Instituto de Estudios de Mastocitosis de Castilla La Mancha, The Clinical Reference Centre of the Spanish Network on Mastocytosis (REMA) , MC, MCAS, Mast cell, Mast cell activation syndrome, REMA, SM, Serum baseline tryptase, Spanish Network on Mastocytosis, Systemic mastocytosis, VIT, Venom immunotherapy, WHO, World Health Organization, anaphylaxis, insect, insect sting anaphylaxis, mastocytosis, sBT

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Indolent systemic mastocytosis (ISM) without skin lesions (ISMs(-)) shows a higher prevalence in males, lower serum baseline tryptase levels, and KIT mutation more frequently restricted to bone marrow (BM) mast cells (MCs) than ISM with skin lesions (ISMs(+)). Interestingly, in almost one-half of ISMs(-) patients, MC-mediator release episodes are triggered exclusively by insects.

          Related collections

          Author and article information

          Journal
          J. Allergy Clin. Immunol.
          The Journal of allergy and clinical immunology
          1097-6825
          0091-6749
          Feb 2014
          : 133
          : 2
          Affiliations
          [1 ] Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain. Electronic address: ivana@sescam.jccm.es.
          [2 ] Section of Haematology, Department of Medicine, University of Verona, Verona, Italy; Multidisciplinary Outpatients Clinics for Mastocytosis, Verona, Italy.
          [3 ] Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Allergy Unit, Hospital de Fuenlabrada, Madrid, Spain.
          [4 ] Multidisciplinary Outpatients Clinics for Mastocytosis, Verona, Italy; Allergy Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
          [5 ] Allergy Department, Hospital de Guadalajara, Guadalajara, Spain.
          [6 ] Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain.
          [7 ] Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Centro de Investigación del Cáncer/IBMCC (USAL/CSIC) and IBSAL, Departamento de Medicina and Servicio General de Citometría, University of Salamanca, Salamanca, Spain.
          [8 ] Multidisciplinary Outpatients Clinics for Mastocytosis, Verona, Italy; Clinical Chemistry and Haematology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
          [9 ] Multidisciplinary Outpatients Clinics for Mastocytosis, Verona, Italy; Section of Rheumatology, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
          [10 ] Multidisciplinary Outpatients Clinics for Mastocytosis, Verona, Italy; Section of Dermatology, Department of Medicine, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
          [11 ] Multidisciplinary Outpatients Clinics for Mastocytosis, Verona, Italy; Department of Pathology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
          [12 ] Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain; Pathology Department, Hospital Virgen de la Salud, Toledo, Spain.
          [13 ] Allergy Unit, Hospital Virgen del Valle, Toledo, Spain.
          [14 ] Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain.
          Article
          S0091-6749(13)00988-3
          10.1016/j.jaci.2013.06.020
          23921094
          ad7d5224-9b09-4df8-9b6d-72090037d193
          Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
          History

          BM,Bone marrow,CLMast,Hymenoptera,ISM,ISMs(+),ISMs(−),Indolent systemic mastocytosis,Indolent systemic mastocytosis with skin lesions,Indolent systemic mastocytosis without skin lesions,Instituto de Estudios de Mastocitosis de Castilla La Mancha, The Clinical Reference Centre of the Spanish Network on Mastocytosis (REMA),MC,MCAS,Mast cell,Mast cell activation syndrome,REMA,SM,Serum baseline tryptase,Spanish Network on Mastocytosis,Systemic mastocytosis,VIT,Venom immunotherapy,WHO,World Health Organization,anaphylaxis,insect,insect sting anaphylaxis,mastocytosis,sBT

          Comments

          Comment on this article